Bayer | BAYN - Gross Profit On Sales



Bayer reported EUR6.38B in Gross Profit on Sales for its fiscal quarter ending in June of 2025.


Gross Profit On Sales Change Date
Air Liquide EUR 8.65B 4.44B Dec/2024
Akzo Nobel EUR 1.04B 10M Jun/2025
Alcon AG USD 1.39B 5M Jun/2025
Amarin USD 25.13M 1.78M Mar/2025
Arkema EUR 441M 18M Mar/2025
AstraZeneca USD 11.98B 637M Jun/2025
BASF EUR 4.18B 675M Jun/2025
Bayer EUR 6.38B 1.74B Jun/2025
Beiersdorf EUR 1.54B 1.16B Jun/2025
Corteva USD 3.36B 1.29B Jun/2025
Covestro EUR 552M 87M Jun/2025
Essilor EUR 8.84B 687M Jun/2025
Fresenius EUR 1.46B 47M Jun/2025
Fresenius Medical Care EUR 1.22B 31M Jun/2025
Genmab DKK 868M 195M Jun/2025
Givaudan CHF 823M 575M Jun/2024
GlaxoSmithKline GBP 5.82B 229M Jun/2025
GRIFOLS EUR 743.8M 49.13M Jun/2025
Henkel EUR 2.65B 2.8B Jun/2025
Hikma Pharmaceutical USD 692M 64M Dec/2024
Johnson Matthey GBP 490M 81M Mar/2025
Linde USD 4.19B 227M Jun/2025
Lonza CHF 1.04B 72M Dec/2024
Merck EUR 3.03B 118M Jun/2025
Novartis USD 11.51B 1.12B Jun/2025
Nutrien USD 3.18B 1.86B Jun/2025
Philips EUR 2.01B 162M Jun/2025
PPG Industries USD 1.63B 86M Jun/2025
Roche Holding CHF 11.69B 48M Dec/2024
Sanofi EUR 7.74B 26M Jun/2025
SAP EUR 6.62B 12M Jun/2025
Solvay EUR 252M 0 Jun/2025
UCB EUR 2.46B 520M Dec/2024
Umicore EUR 308.6M 10.45M Dec/2024
Vinci EUR 2.44B 27.34B Jun/2025